-+ 0.00%
-+ 0.00%
-+ 0.00%

SILEXION THERAPEUTICS ANNOUNCES POSITIVE NEW HUMAN CELL LINE DATA CONFIRMING PAN-KRAS ACTIVITY OF SIL204, DEMONSTRATING UP TO 99.7% INHIBITION AND FIRST EVIDENCE IN GASTRIC CANCER

Reuters·09/30/2025 12:40:00

Please log in to view news